​

IDEXX Laboratories (IDXX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

IDXX Stock Forecast

IDEXX Laboratories (IDXX) stock forecast, based on 22 Wall Street analysts, predicts a 12-month average price target of $803.57, with a high of $850.00 and a low of $750.00. This represents a 13.54% increase from the last price of $707.76.

$400 $490 $580 $670 $760 $850 High: $850 Avg: $803.57 Low: $750 Last Closed Price: $707.76

IDXX Stock Rating

IDEXX Laboratories stock's rating consensus is Buy, based on 22 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (59.09%), 8 Hold (36.36%), 1 Sell (4.55%), and 0 Strong Sell (0.00%).

Buy
Total 22 0 1 8 13 Strong Sell Sell Hold Buy Strong Buy

IDXX Price Target Upside V Benchmarks

TypeNameUpside
StockIDEXX Laboratories13.54%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks6.89%

Price Target Trends

1M3M12M
# Anlaysts1912
Avg Price Target$850.00$782.78$766.00
Last Closing Price$707.76$707.76$707.76
Upside/Downside20.10%10.60%8.23%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 253551-14
Nov, 253561116
Oct, 25346-114
Sep, 25345-113
Aug, 253451-13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 08, 2025Glen SantangeloBarclays$850.00$706.6520.29%20.10%
Nov 04, 2025Morgan Stanley$805.00$721.0411.64%13.74%
Nov 04, 2025UBS$750.00$722.943.74%5.97%
Nov 04, 2025BTIG$830.00$722.9414.81%17.27%
Nov 04, 2025Keith DevasJefferies$830.00$722.9414.81%17.27%
Nov 03, 2025Leerink Partners$785.00$722.948.58%10.91%
Nov 03, 2025Jonathan BlockStifel Nicolaus$775.00$722.947.20%9.50%
Oct 31, 2025Jonathan BlockStifel Nicolaus$700.00$628.5411.37%-1.10%
Oct 01, 2025Andrea AlfonsoUBS$720.00$638.8912.70%1.73%
Aug 05, 2025Morgan Stanley$722.00$641.9412.47%2.01%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 08, 2025BarclaysOverweightOverweightinitialise
Nov 04, 2025Morgan StanleyOverweightOverweighthold
Nov 04, 2025UBSNeutralNeutralhold
Nov 04, 2025BTIGBuyBuyhold
Nov 04, 2025JefferiesBuyBuyhold
Oct 01, 2025UBSNeutralinitialise
Aug 11, 2025Piper SandlerNeutralNeutralhold
Aug 05, 2025Morgan StanleyOverweightOverweighthold
Aug 05, 2025BTIGBuyBuyhold
Feb 04, 2025BarclaysOverweightOverweighthold

Financial Forecast

EPS Forecast

$5 $8 $11 $14 $17 $20 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.82$8.74$8.12$10.17$10.79----
Avg Forecast$6.10$8.38$7.91$9.86$10.46$11.97$13.55$15.48$16.93
High Forecast$6.19$8.50$7.99$9.92$10.54$12.22$14.03$16.33$17.13
Low Forecast$6.04$8.30$7.82$9.81$10.40$11.75$12.84$14.21$16.70
Surprise %11.80%4.30%2.65%3.14%3.15%----

Revenue Forecast

$3B $3B $4B $4B $5B $6B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.71B$3.22B$3.37B$3.66B$3.90B----
Avg Forecast$2.67B$3.19B$3.36B$3.65B$3.88B$4.15B$4.51B$4.95B$5.39B
High Forecast$2.70B$3.23B$3.38B$3.66B$3.89B$4.18B$4.52B$4.95B$5.44B
Low Forecast$2.65B$3.17B$3.33B$3.64B$3.84B$4.12B$4.50B$4.94B$5.34B
Surprise %1.49%0.65%0.28%0.33%0.49%----

Net Income Forecast

$0 $300M $600M $900M $1B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$581.78M$744.85M$679.09M$845.04M$887.87M----
Avg Forecast$418.39M$604.02M$662.67M$845.04M$878.93M$1.01B$1.10B$1.22B$1.42B
High Forecast$502.06M$724.83M$795.20M$1.01B$884.81M$1.03B$1.18B$1.37B$1.44B
Low Forecast$334.71M$483.22M$530.13M$676.03M$873.04M$986.97M$1.08B$1.19B$1.40B
Surprise %39.05%23.31%2.48%-1.02%----

IDXX Forecast FAQ

Is IDEXX Laboratories stock a buy?

IDEXX Laboratories stock has a consensus rating of Buy, based on 22 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 8 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that IDEXX Laboratories is a favorable investment for most analysts.

What is IDEXX Laboratories's price target?

IDEXX Laboratories's price target, set by 22 Wall Street analysts, averages $803.57 over the next 12 months. The price target range spans from $750 at the low end to $850 at the high end, suggesting a potential 13.54% change from the previous closing price of $707.76.

How does IDEXX Laboratories stock forecast compare to its benchmarks?

IDEXX Laboratories's stock forecast shows a 13.54% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (6.89%).

What is the breakdown of analyst ratings for IDEXX Laboratories over the past three months?

  • December 2025: 21.43% Strong Buy, 35.71% Buy, 35.71% Hold, 7.14% Sell, 0% Strong Sell.
  • November 2025: 18.75% Strong Buy, 31.25% Buy, 37.50% Hold, 6.25% Sell, 6.25% Strong Sell.
  • October 2025: 21.43% Strong Buy, 28.57% Buy, 42.86% Hold, 0% Sell, 7.14% Strong Sell.

What is IDEXX Laboratories’s EPS forecast?

IDEXX Laboratories's average annual EPS forecast for its fiscal year ending in December 2025 is $11.97, marking a 10.94% increase from the reported $10.79 in 2024. Estimates for the following years are $13.55 in 2026, $15.48 in 2027, and $16.93 in 2028.

What is IDEXX Laboratories’s revenue forecast?

IDEXX Laboratories's average annual revenue forecast for its fiscal year ending in December 2025 is $4.15B, reflecting a 6.58% increase from the reported $3.9B in 2024. The forecast for 2026 is $4.51B, followed by $4.95B for 2027, and $5.39B for 2028.

What is IDEXX Laboratories’s net income forecast?

IDEXX Laboratories's net income forecast for the fiscal year ending in December 2025 stands at $1.01B, representing an 13.38% increase from the reported $887.87M in 2024. Projections indicate $1.1B in 2026, $1.22B in 2027, and $1.42B in 2028.